News Hub

Apr 1, 2026

Maya Rios

Press Releases

Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

Roivant Sciences announced the expansion of its brepocitinib development program to include a new seamless Phase 2b/3 clinical trial for the inflammatory scalp disorder lichen planopilaris (LPP), which currently has no FDA-approved treatments. Concurrently, Roivant reported topline results from Immunovant's Phase 3 studies of batoclimab in thyroid …

ROIV

Apr 1, 2026

Sofia Navarro

Press Releases

Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP)

Priovant Therapeutics announced the initiation of a seamless Phase 2b/3 clinical trial for brepocitinib in treating Lichen Planopilaris (LPP), a severe inflammatory scalp disorder with no FDA-approved treatments. This marks the fourth indication in brepocitinib's late-stage development alongside dermatomyositis, non-infectious uveitis, and cutaneou…

ROIV

Apr 1, 2026

Sofia Navarro

Press Releases

Futu Announces Cash Dividend

Futu Holdings Limited, a Nasdaq-listed online brokerage and wealth management platform, declared a cash dividend of $0.325 per ordinary share (equivalent to $2.6 per American Depositary Share), totaling approximately $365 million, payable to shareholders as of April 16, 2026, with payment expected around April 29, 2026.

FUTU

Apr 1, 2026

Jordan Park

Press Releases

Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

Immunovant announced that its Phase 3 clinical trials for batoclimab in treating thyroid eye disease (TED) failed to meet their primary efficacy endpoint. While safety profiles were consistent with previous results and no new risks identified, the drug did not achieve the targeted proptosis improvement at 24 weeks. The company highlighted promising…

IMVT

Apr 1, 2026

Sofia Navarro

Press Releases

Celldex Announces Pricing of $300 Million Public Offering of Common Stock

Celldex Therapeutics, a clinical-stage biotechnology company, announced the pricing of an underwritten public offering of 10,345,000 shares at $29.00 per share, expecting gross proceeds of approximately $300 million. The offering aims to fund its commercial readiness and potential launch of barzolvolimab for chronic spontaneous urticaria, continue …

CLDX

Apr 1, 2026

Avery Klein

World

Bahamas Prime Minister Calls Early Vote for May 12 as Cost-of-Living Measures Announced

The Bahamian government has announced an early national election for May 12, with Prime Minister Philip Davis scheduling the dissolution of parliament on April 8 and formally calling the vote the next day. The move comes alongside a decision to eliminate value-added tax on unprepared grocery items as officials seek to address a cost-of-living ranke…

Apr 1, 2026

Nina Shah

Insider Trading

Director Ault Acquires Additional Universal Safety Products Shares; Company Converts Note to Equity

Universal Safety Products, Inc. (NASDAQ: UUU) disclosed that director Ault Milton C III purchased shares totaling $72,808 across transactions on March 30 and 31. The company also reported issuing 405,000 shares between January 26 and February 3 as part of a convertible note conversion totaling $1,503,424.80, executed under a Section 4(a)(2) exempti…

Apr 1, 2026

Jordan Park

World

Seven-Month-Old Killed by Stray Gunfire in Brooklyn; Suspect in Custody

A 7-month-old girl riding in a stroller was shot and killed on a Brooklyn street during an apparent gang-related exchange of gunfire. City officials say the child was an unintended target; one suspect has been taken into custody and police continue to seek a second man seen fleeing the scene on a moped.

Apr 1, 2026

Ajmal Hussain

Stock Markets

Administration Plans Steep Tariffs for Drugmakers Lacking U.S. Pricing Deals

U.S. officials are preparing to announce tariffs on pharmaceutical companies that have not struck deals to guarantee lower prices domestically, with a potential 100% tariff on imported branded and patented medicines. Some multinational drugmakers have negotiated exemptions by committing to pricing arrangements and U.S. investment, while others have…

Apr 1, 2026

Leila Farooq

Insider Trading

Kratos US President Sells $487K in Stock as Company Lands Multiple Defense and Space Contracts

Steven S. Fendley, President of Kratos Defense & Security Solutions' U.S. division, sold 6,998 shares of the company's common stock on March 30, 2026, realizing about $487,119. The transactions occurred under a 10b5-1 trading plan adopted May 12, 2025. The move comes as Kratos shares have fallen 15% over the prior week but remain up 131% year-over-…

Apr 1, 2026

Nina Shah

Stock Markets

Globalstar Stock Climbs to 18-Year High After Report of Amazon Acquisition Talks

Globalstar Inc. shares rallied sharply in after-hours trade after reports indicated Amazon is in discussions to acquire the satellite telecommunications company. The stock jumped roughly 16% to $79.70, its highest level since early 2008. Media coverage said the potential deal would bolster Amazon's low Earth orbit satellite ambitions and position i…

Apr 1, 2026

Caleb Monroe

Insider Trading

MediaAlpha Director Sells 12,000 Shares in Three Trades to Cover RSU Taxes

MediaAlpha director Steven Yi reported the sale of 12,000 shares of Class A common stock across three trades from March 30 to April 1, 2026, raising $111,907. The transactions, disclosed on a Form 4 filing, were executed under a Rule 10b5-1 trading plan to cover tax liabilities from vested restricted stock units. The company recently posted Q4 2025…

Apr 1, 2026

Jordan Park

Insider Trading

Major Caddis Stake Reduction in Fermi Inc. Totals $56.3 Million as Shares Slip

Caddis Holdings, LP, a roughly 10% shareholder in Fermi Inc. (FRMI), disposed of 11,000,000 shares of common stock in two transactions on March 30 and March 31, 2026, generating approximately $56,268,500. The sales occurred as Fermi's shares experienced pronounced volatility, falling 19% over the prior week and 83% over the trailing year. Following…

Apr 1, 2026

Priya Menon

Insider Trading

Realty Income Director Disposes $202K in Shares as Company Advances Financing and JV Plans

Realty Income Corp director Gregory McLaughlin sold 3,275 shares on April 1, 2026, for $61.87 apiece, totaling $202,624. The transaction leaves McLaughlin with 34,993 shares held by a family trust. The REIT, with a market value of $57.86 billion and a 5.25% dividend yield, is trading above its InvestingPro Fair Value. Separately, the company priced…

Apr 1, 2026

Maya Rios

Stock Markets

Goldman: Hedge Funds Suffer Largest Monthly Drawdown Since January 2022 Amid Iran War Volatility

Goldman Sachs reported that global hedge funds endured their worst monthly drawdown since January 2022, driven by market turbulence associated with the Iran war and rapid shifts across rates, currencies, commodities and equity factor rotations. Fundamental long/short stockpickers were broadly negative in March, with Asia-focused managers hit hardes…

Apr 1, 2026

Sofia Navarro

Insider Trading

Cheniere Energy Executive Disposes $8.7M in Shares; Company Posts Strong Q4 2025 Results

Cheniere Energy EVP and CFO Zach Davis sold 29,000 shares of common stock on March 30, 2026, for $300 per share, a transaction valued at $8.7 million. After the sale Davis holds 87,146 shares. Independent valuation commentary cites potential overvaluation versus Fair Value despite a P/E of 11.38. Separately, Cheniere reported strong fourth-quarter …

Apr 1, 2026

Jordan Park

Insider Trading

Tesla Director Disposes of $9.27M in Shares, Exercises Options for 40,000 Shares

Tesla director Kathleen Wilson-Thompson sold 20,008 shares on March 30, 2026 for roughly $9.27 million and exercised options to acquire 40,000 additional shares at $14.99 each. The transactions leave her with 47,748 shares directly owned. The moves occur amid divergent analyst price targets and commentary on deliveries and regional demand.

Apr 1, 2026

Nina Shah

Insider Trading

Kymera Director Elena Ridloff Sells More Than $1 Million in KYMR Shares; Exercises Options

Elena Ridloff, a director at Kymera Therapeutics, sold 12,000 shares of the company's common stock on March 31 and April 1, 2026, for just over $1 million. The transactions, reported on a Form 4 with the SEC, occurred at prices between $85.1946 and $86.05. On those same dates she exercised options to buy 12,000 shares at $14.18 per share. Separatel…

Apr 1, 2026

Leila Farooq

Insider Trading

Kymera COO Executes Share Sale, Locks in Roughly $1.9M After Strong Stock Rally

Kymera Therapeutics Chief Operating Officer Jeremy G. Chadwick sold 22,240 shares across March 31 and April 1, 2026, for about $1.9 million, executing trades under a pre-arranged Rule 10b5-1 plan. The transactions coincided with a year of strong stock performance and followed option exercises that acquired the same number of shares at a strike of $…

Apr 1, 2026

Caleb Monroe

Insider Trading

C3.ai CEO Reduces Direct Stake with $429,092 Sale as Shares Trade Near Yearly Low

C3.ai Chief Executive Officer Stephen Bradley Ehikian sold 52,194 Class A shares on March 31 for roughly $429,092, trimming his direct stake to 721,485 shares. The transactions coincide with the stock trading close to its 52-week low and follow disappointing quarterly results and lowered guidance that prompted multiple analyst target cuts.

Apr 1, 2026

Ajmal Hussain

Stock Markets

Auto Industry Group Proposes Replacing Federal Gas Tax With Weight-Based Vehicle Fee

The head of the Alliance for Automotive Innovation has proposed eliminating the federal 18.4-cent per gallon gasoline tax and substituting a uniform vehicle fee based on weight to fund road repairs. The recommendation aims to address a growing shortfall in the Highway Trust Fund driven by more fuel-efficient vehicles and rising electric vehicle ado…

Apr 1, 2026

Marcus Reed

Insider Trading

Velocity Financial CFO Disposes of $28,518 in Shares as Valuation Questions Persist

Velocity Financial, Inc. (NASDAQ: VEL) saw its chief financial officer, Mark R. Szczepaniak, sell 1,573 shares on April 1, 2026, for $18.13 apiece, generating $28,518 in proceeds. The move leaves him with 101,535 shares held directly and 71,546 held indirectly via a family trust. The transaction coincides with a company trading at a P/E of 6.56 and…

Apr 1, 2026

Ajmal Hussain

Stock Markets

A timeline of NASA’s Artemis program and the path back to the lunar surface

NASA’s Artemis program is the United States’ multi-year effort to return astronauts to the Moon after the Apollo era and to create a lasting human presence there. The program, organized around the Space Launch System rocket and the Orion crew capsule and relying on commercially developed lunar landers, has moved through a sequence of milestones sin…

Apr 1, 2026

Priya Menon

World

Inside Artemis II: A day-by-day account of NASA’s crewed lunar flight

Launched on April 1, NASA’s Artemis II is a roughly 10-day crewed mission that will carry four astronauts on a high-velocity trajectory around the Moon and back. The flight is the first human lunar mission since the Apollo program and is intended to validate spacecraft systems and operations needed for planned landings later this decade. The missio…

Apr 1, 2026

Hana Yamamoto

Commodities

Australia to lend A$1 billion interest-free to critical firms to ease fuel cost squeeze

The Australian government will make up to A$1 billion in interest-free loans available to businesses deemed essential to critical supply chains, including transport operators and fertiliser producers, to help them cope with rising fuel costs linked to disruptions from the Iran war. The move is framed as a short-term buffer against global shocks and…